EPCAM and hepatocellular carcinoma: While we assessed HPC marker expression in resected HCC specimens by immunohistochemistry, a new method for testing HPC markers in circulating tumour cells obtained by liquid biopsy is being developed, and the relationship between EpCAM expression in liquid biopsy samples and poor prognosis in HCC has been reported [38, 39].